You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
22 October 2026 - The Institute for Healthcare Improvement (IHI) and biopharmaceutical company Bristol Myers Squibb (NYSE:BMY) on Thursday launched a three-year Cancer Collective Action Collaborative to expand access to and participation in oncology ...
21 October 2026 - Swiss pharmaceutical company Novartis AG (SIX: NOVN; NYSE: NVS) on Wednesday said the European Commission has approved Cosentyx (secukinumab) for adults with polymyalgia rheumatica (PMR) who have had an inadequate response to glucoc...
21 October 2026 - Edwards Lifesciences Corporation (NYSE: EW), a structural heart innovation company, announced on Wednesday that it has received US Food and Drug Administration (FDA) approval for its PASCAL Precision system to repair the tricuspid v...
21 October 2026 - Specialist HIV company ViiV Healthcare, majority owned by GSK (LON:GSK), with Shionogi as a shareholder, on Wednesday reported five-year real-world data from the US OPERA observational cohort showing sustained viral suppression and ...
21 October 2026 - Biopharmaceutical oncology company Summit Therapeutics Inc (NASDAQ:SMMT) said on Wednesday that it has partnered with the ECOG-ACRIN Cancer Research Group to evaluate ivonescimab in a registration-enabling Phase II/III clinical tria...
20 October 2026 - Abbott Laboratories (NYSE: ABT), a global healthcare company, said on Tuesday that Cologuard Plus has received CE Mark approval under the European Union's In Vitro Diagnostic Medical Devices Regulation, clearing the way for its...
20 October 2026 - Solventum Corporation (NYSE: SOLV), a US-based company involved in advanced wound healing, announced on Monday that the US Food and Drug Administration (FDA) has granted 510(k) clearance for the combined use of Restrata Synthetic El...